UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them

Journal of Immunology Research, 2019-01, Vol.2019 (2019), p.1-9

2019

Volltextzugriff (PDF)

Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma

Molecular cancer therapeutics, 2017-03, Vol.16 (3), p.516-528

2017

Volltextzugriff (PDF)

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

Immunologic research, 2011-12, Vol.51 (2-3), p.170-182

2011

Volltextzugriff (PDF)

Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma

Cancer research (Chicago, Ill.), 2015-07, Vol.75 (13), p.2737-2748

2015

Volltextzugriff (PDF)

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

Cell reports (Cambridge), 2017-11, Vol.21 (7), p.1953-1967

2017

Volltextzugriff (PDF)

Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress

Science signaling, 2024-06, Vol.17 (840), p.eadn8376

2024

Volltextzugriff (PDF)

A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma

Scientific reports, 2024-05, Vol.14 (1), p.10529-10529, Article 10529

2024

Volltextzugriff (PDF)

Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma

Cancers, 2020-02, Vol.12 (2), p.405

2020

Volltextzugriff (PDF)

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma

EMBO molecular medicine, 2019-02, Vol.11 (2), p.1-n/a

2019

Volltextzugriff (PDF)

Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma

Journal of translational medicine, 2020-05, Vol.18 (1), p.208-208, Article 208

2020

Volltextzugriff (PDF)

Individualised neoantigen cancer vaccine therapy

The Lancet (British edition), 2024-02, Vol.403 (10427), p.590-591

2024

Volltextzugriff (PDF)

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma

Immunotherapy, 2017-12, Vol.9 (16), p.1323-1330

2017

Volltextzugriff (PDF)

Abstract 1137: PRMT5 inhibition regulates alternative splicing and DNA damage repair pathways in SF3B1 R625G expressing uveal melanoma cells

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1137-1137

2021

Volltextzugriff (PDF)

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis

Journal of translational medicine, 2017-06, Vol.15 (1), p.145-145, Article 145

2017

Volltextzugriff (PDF)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

Cancers, 2021-11, Vol.13 (22), p.5749

2021

Volltextzugriff (PDF)

Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte–Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases

Journal of vascular and interventional radiology, 2015-04, Vol.26 (4), p.523-532.e2

2015

Volltextzugriff (PDF)

Improved Uveal Melanoma Copy Number Subtypes Including an Ultra–High-Risk Group

Ophthalmology science (Online), 2022-06, Vol.2 (2), p.100121-100121, Article 100121

2022

Volltextzugriff (PDF)

Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5436-5442

2008

Volltextzugriff (PDF)

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells

EBioMedicine, 2015-11, Vol.2 (11), p.1821-1826

2015

Volltextzugriff (PDF)

Immunological aspect of the liver and metastatic uveal melanoma

Journal of cancer metastasis and treatment, 2017-10, Vol.3 (10), p.231

2017

Volltextzugriff (PDF)

Interleukin 6 mediates production of interleukin 10 in metastatic melanoma

Cancer Immunology, Immunotherapy, 2012-02, Vol.61 (2), p.145-155

2012

Volltextzugriff (PDF)

Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment

Clinical cancer drugs, 2015-05, Vol.2 (1), p.4-15

2015

Volltextzugriff (PDF)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma

Cancers, 2021-10, Vol.13 (21), p.5457

2021

Volltextzugriff (PDF)

Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs

The Journal of biological chemistry, 2021-09, Vol.297 (3), p.101033-101033, Article 101033

2021

Volltextzugriff (PDF)

HLA discordance between blood and tumor: A treatment conundrum?

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21577-e21577

2023

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them

Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress

A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma

Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma

Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma

Individualised neoantigen cancer vaccine therapy

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma

Abstract 1137: PRMT5 inhibition regulates alternative splicing and DNA damage repair pathways in SF3B1 R625G expressing uveal melanoma cells

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte–Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases

Improved Uveal Melanoma Copy Number Subtypes Including an Ultra–High-Risk Group

Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells

Immunological aspect of the liver and metastatic uveal melanoma

Interleukin 6 mediates production of interleukin 10 in metastatic melanoma

Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma

Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs

HLA discordance between blood and tumor: A treatment conundrum?

Suchergebnisse filtern